1. Morrissey, Samantha M, Zhang, Fan, Ding, Chuanlin, Huang, Jian, Yan, Jun. 2021. Tumor-derived exosomes drive immunosuppressive macrophages in a pre-metastatic niche through glycolytic dominant metabolic reprogramming. In Cell metabolism, 33, 2040-2058.e10. doi:10.1016/j.cmet.2021.09.002. https://pubmed.ncbi.nlm.nih.gov/34559989/
2. Zhang, Liming, Wang, Shaoqiang, Wang, Lina. 2024. Comprehensive analysis identifies YKT6 as a potential prognostic and diagnostic biomarker in lung adenocarcinoma. In BMC cancer, 24, 1235. doi:10.1186/s12885-024-12975-3. https://pubmed.ncbi.nlm.nih.gov/39375639/
3. Xu, Jia-Ze, Jiang, Jun-Jie, Xu, Hao-Jie, Liu, Zheng-Chuang, Hu, Zhi-Ming. 2021. High expression of YKT6 associated with progression and poor prognosis of hepatocellular carcinoma. In Scandinavian journal of gastroenterology, 56, 1349-1354. doi:10.1080/00365521.2021.1961305. https://pubmed.ncbi.nlm.nih.gov/34396876/
4. Ji, Jie, Yu, Yiping, Wu, Shaowen, Weng, Jingwei, Wang, Wenning. 2023. Different conformational dynamics of SNARE protein Ykt6 among yeast and mammals. In The Journal of biological chemistry, 299, 104968. doi:10.1016/j.jbc.2023.104968. https://pubmed.ncbi.nlm.nih.gov/37380075/
5. Yang, Zongcheng, Yan, Guangxing, Zheng, Lixin, Fu, Yue, Xu, Xin. 2021. YKT6, as a potential predictor of prognosis and immunotherapy response for oral squamous cell carcinoma, is related to cell invasion, metastasis, and CD8+ T cell infiltration. In Oncoimmunology, 10, 1938890. doi:10.1080/2162402X.2021.1938890. https://pubmed.ncbi.nlm.nih.gov/34221701/
6. Liu, Jiamin, Zhang, Qiang, He, Ling, Wang, Yixuan, Xie, Ping. 2025. Pan-Cancer Analysis Identifies YKT6 as a Prognostic and Immunotherapy Biomarker, with an Emphasis on Cervical Cancer. In OncoTargets and therapy, 18, 107-127. doi:10.2147/OTT.S491310. https://pubmed.ncbi.nlm.nih.gov/39867862/
智鼠故事 
